MDPI and ACS Style
Lee, J.; Han, J.-W.; Sung, P.-S.; Lee, S.-K.; Yang, H.; Nam, H.-C.; Yoo, S.-H.; Lee, H.-L.; Kim, H.-Y.; Lee, S.-W.;
et al. Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study. J. Clin. Med. 2021, 10, 4045.
https://doi.org/10.3390/jcm10184045
AMA Style
Lee J, Han J-W, Sung P-S, Lee S-K, Yang H, Nam H-C, Yoo S-H, Lee H-L, Kim H-Y, Lee S-W,
et al. Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study. Journal of Clinical Medicine. 2021; 10(18):4045.
https://doi.org/10.3390/jcm10184045
Chicago/Turabian Style
Lee, Jaejun, Ji-Won Han, Pil-Soo Sung, Soon-Kyu Lee, Hyun Yang, Hee-Chul Nam, Sun-Hong Yoo, Hae-Lim Lee, Hee-Yeon Kim, Sung-Won Lee,
and et al. 2021. "Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study" Journal of Clinical Medicine 10, no. 18: 4045.
https://doi.org/10.3390/jcm10184045